229 related articles for article (PubMed ID: 6781341)
21. Individual sulfonylureas and serious hypoglycemia in older people.
Shorr RI; Ray WA; Daugherty JR; Griffin MR
J Am Geriatr Soc; 1996 Jul; 44(7):751-5. PubMed ID: 8675920
[TBL] [Abstract][Full Text] [Related]
22. [Oral antidiabetics. Dose, plasma concentration and effect].
Ariëns EJ
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():143-76. PubMed ID: 4392071
[No Abstract] [Full Text] [Related]
23. Antidiabetic agents.
Francisco GE
Prim Care; 1990 Sep; 17(3):499-519. PubMed ID: 2236334
[TBL] [Abstract][Full Text] [Related]
24. Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in beta-cell-rich pancreatic islets.
Hellman B; Sehlin J; Täljedal IB
Acta Endocrinol (Copenh); 1984 Mar; 105(3):385-90. PubMed ID: 6230850
[TBL] [Abstract][Full Text] [Related]
25. Effects of sulfonylurea on the secretion and disposition of insulin and C-peptide.
Almér LO; Johansson E; Melander A; Wåhlin-Boll E
Acta Med Scand Suppl; 1981; 656():11-8. PubMed ID: 7046346
[TBL] [Abstract][Full Text] [Related]
26. Proceedings: Half-life of phenprocoumarol (Marcumar R) during treatment with insulin and sulfonylureas in diabetics.
Heine P; Kewitz H; Wiegboldt KA
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R30. PubMed ID: 4276557
[No Abstract] [Full Text] [Related]
27. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
[No Abstract] [Full Text] [Related]
28. Adsorption of sulfonylureas onto activated charcoal in vitro.
Kannisto H; Neuvonen PJ
J Pharm Sci; 1984 Feb; 73(2):253-6. PubMed ID: 6707896
[TBL] [Abstract][Full Text] [Related]
29. Long-term results with oral hypoglycemic drugs.
Moss JM; DeLawter DE
J Am Geriatr Soc; 1973 Feb; 21(2):72-6. PubMed ID: 4688111
[No Abstract] [Full Text] [Related]
30. Sulfonylureas enhance in vivo the effectiveness of insulin in type 1 (insulin dependent) diabetes mellitus.
Pontiroli AE; Alberetto M; Bertoletti A; Baio G; Pozza G
Horm Metab Res; 1984 Dec; 16 Suppl 1():167-70. PubMed ID: 6398258
[TBL] [Abstract][Full Text] [Related]
31. Oral hypoglycemic agents.
Ferner RE
Med Clin North Am; 1988 Nov; 72(6):1323-35. PubMed ID: 3054355
[TBL] [Abstract][Full Text] [Related]
32. Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects.
Gavin JR
Am J Med; 1985 Sep; 79(3B):34-42. PubMed ID: 3931460
[TBL] [Abstract][Full Text] [Related]
33. Influence of sulfonylureas on the secretion, disposal and effect of insulin.
Almér LO; Johansson E; Melander A; Wåhlin-Boll E
Eur J Clin Pharmacol; 1982; 22(1):27-32. PubMed ID: 7047169
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
35. Impaired effect of sulfonylurea following increased dosage.
Wåhlin-Boll E; Sartor G; Melander A; Scherstén B
Eur J Clin Pharmacol; 1982; 22(1):21-5. PubMed ID: 7047168
[TBL] [Abstract][Full Text] [Related]
36. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs.
Zhang CL; Katoh M; Shibasaki T; Minami K; Sunaga Y; Takahashi H; Yokoi N; Iwasaki M; Miki T; Seino S
Science; 2009 Jul; 325(5940):607-10. PubMed ID: 19644119
[TBL] [Abstract][Full Text] [Related]
37. A quantum chemical study with special reference to the sulfamyl group of sulfonylureas.
Orita Y; Ando A; Takamitsu Y; Urakabe S; Shirai D
Jpn Circ J; 1970 Sep; 34(9):775-8. PubMed ID: 5537674
[No Abstract] [Full Text] [Related]
38. Diabetes mellitus: the thin maturity-onset diabetic.
Br Med J; 1972 Sep; 3(5828):692-4. PubMed ID: 4631184
[No Abstract] [Full Text] [Related]
39. Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus.
Kabadi MU; Kabadi UM
Ann Pharmacother; 2003 Nov; 37(11):1572-6. PubMed ID: 14565810
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
